NCT00660088View on ClinicalTrials.gov

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Alzheimer's Disease
Interventions
OTHER

Ketasyn

10g for 7 days, 20g for 7 or 14 days

Trial Locations (1)

33709

Meridien Research Center, St. Petersburg

Sponsors

Lead Sponsor

Cerecin
All Listed Sponsors
lead

Cerecin

INDUSTRY